Post-Market Safety Registries
Safety monitoring registries tracking long-term outcomes and adverse events after psychedelic therapy in real-world clinical settings.
- Organisations
- 14
- Countries
- 1
By country
Registry and data source comparison
| Organisation | Data Type | Access Model | Update Cadence |
|---|---|---|---|
| America's Poison Centers | Safety surveillance data | Case-by-case access | Real-time / continuous |
| EMA EudraVigilance | Safety surveillance data | Open access | Weekly |
| FDA Adverse Event Monitoring System (AEMS) | Safety surveillance data | Open access | Weekly |
| FDA MedWatch | Safety surveillance data | Open access | Weekly |
| Health Canada Canada Vigilance | Safety surveillance data | Open access | Weekly |
| MHRA Yellow Card | Safety surveillance data | Open access | Weekly |
| Medsafe & CARM Pharmacovigilance | Safety surveillance data | Open access | Weekly |
| Netherlands Pharmacovigilance Centre Lareb | Safety surveillance data | Open access | Weekly |
| Rocky Mountain Poison & Drug Safety | Safety surveillance data | Case-by-case access | Daily |
| Singapore HSA Adverse Event Reporting | Safety surveillance data | Open access | Weekly |
| Swissmedic ElViS | Safety surveillance data | Registration required | Weekly |
| TGA DAEN | Safety surveillance data | Open access | Weekly |
| Uppsala Monitoring Centre | Safety surveillance data | Case-by-case access | Daily |
Showing the first 40 organisations with profile data; use the filters below to narrow the full list.
All Organisations
America's Poison Centers
US network of poison centers and national data system (NPDS) for toxicology and pharmacovigilance surveillance.
Citeline
Citeline (formerly Informa Pharma Intelligence) is a global pharmaceutical data and clinical intelligence platform providing AI-driven drug pipeline tracking, trial monitoring, and R&D analytics to life sciences organisations. It is referenced as a data source in the Department of Defense PTSD Adaptive Platform Trial involving SLS-002 (esketamine intranasal spray).
EMA EudraVigilance
European pharmacovigilance system for suspected adverse drug reaction reporting. Psychedelic relevance: EMA has hosted a multi-stakeholder psychedelics regulatory workshop and EudraVigilance is the key EU safety channel.
FDA Adverse Event Monitoring System (AEMS)
US FDA adverse-event monitoring infrastructure for regulated products. Psychedelic relevance: FDA has issued draft clinical trial guidance for psychedelic drugs and AEMS is the active public safety-monitoring surface.
FDA MedWatch
US FDA adverse-event and product-problem reporting program with public safety communications and reporting channels.
Health Canada Canada Vigilance
National adverse reaction reporting and access database for marketed health products in Canada. Psychedelic relevance: Health Canada publishes psilocybin-specific clinical-trial and special-access policy notices.
MHRA Yellow Card
UK safety reporting program for medicine and device adverse events. Psychedelic relevance: UK has active policy and trial activity, while public MHRA records indicate no authorized psilocybin medicinal product yet.
Medsafe & CARM Pharmacovigilance
New Zealand pharmacovigilance infrastructure operated through Medsafe and CARM for adverse-reaction reporting, analysis, and signal monitoring. Public psychedelic-specific dashboards are limited; this profile is included as core safety infrastructure.
Netherlands Pharmacovigilance Centre Lareb
National pharmacovigilance centre for the Netherlands supporting adverse drug reaction reporting, signal detection, and patient-reporting channels. Public psychedelic-specific evidence views are limited; this profile is included as core safety infrastructure.
Rocky Mountain Poison & Drug Safety
US poison center and toxicology surveillance organization supporting data collection and safety monitoring operations.
Singapore HSA Adverse Event Reporting
Singapore Health Sciences Authority adverse-event reporting framework for therapeutic products and clinical trials. Included as core safety-monitoring infrastructure; no dedicated psychedelic public reporting surface identified.
Swissmedic ElViS
Swissmedic electronic vigilance infrastructure for adverse drug reaction reporting by healthcare professionals and companies in Switzerland. Included as core safety infrastructure; psychedelic-specific public slices are limited.
TGA DAEN
Australian adverse-event notification database and safety-monitoring framework. Psychedelic relevance: TGA publishes dedicated policy and access guidance for MDMA and psilocybin use.
Uppsala Monitoring Centre
WHO collaborating centre for international drug safety monitoring, stewarding VigiBase and global pharmacovigilance methods.